Travere Therapeutics grew its share prices by 40.78 percent week-on-week, as investors increased their positions after ...

Marathon footage in this video is from 2025’s race JERSEY CITY, N.J. (PIX11) — There were 11,000 runners in the Jersey City ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the 10 Overlooked Growth Stocks to Buy Now.

Jade Biosciences is a pre-revenue biotech focused on JADE101 for IgA nephropathy, offering potential. Read why I rate JBIO ...

Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...

RITTMAN, Ohio — Tanya Stehler was 8 years old when a routine doctor's visit turned into an emergency. She had been ...

Allison Kentosh kept her friend alive by donating a kidney, then earned a "Life Saving Certificate" from the Civil Air Patrol ...

The U.S. Food and Drug Administration has approved the expanded use of ​Travere Therapeutics' drug to treat a rare kidney ...

The FDA has greenlit Travere Therapeutics’ Filspari as the only available treatment for focal segmental glomerulosclerosis ...

Monday’s FDA approval makes Filspari the first therapy specifically indicated for FSGS, a condition that represents a $1 ...

Not everyone with IgA nephropathy will need steroids, but for some, these medications can help protect kidney function. Here’s a closer look at the benefits, risks, and side effects.